Clinical trials
Recruiting Phase 2 Esophageal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 12 |
| 2024 | 22 |
| 2025 | 22 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 6 |
| Tianjin Medical University Cancer Institute and Hospital | 5 |
| The First Affiliated Hospital of Zhengzhou University | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| OHSU Knight Cancer Institute | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| Shanghai Chest Hospital | 2 |
| Sichuan University | 2 |
| Zhejiang Cancer Hospital | 2 |
| AHS Cancer Control Alberta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 74 |
| Esophageal Squamous Cell Carcinoma | 13 |
| Stomach Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Breast Neoplasms | 5 |
| Colorectal Neoplasms | 5 |
| Lung Neoplasms | 5 |
| Gastrointestinal Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.